news.cancerconnect.com

GENERAL
META
HTML
LINK ANALYSIS
SERVER

News.cancerconnect.com receives any estimated 921 unique visitors and 1,177 unique page views per day. Revenue gained from these much visits may be $1 per day from various advertising sources. The estimated worth of site is $412. Similarweb global rank is 1,642,137. Maximum no. of users comes from .

Amazon.com, Inc. is ISP, hosted on IP 35.163.221.159 in Country United States.

Website Age n/a
Alexa Rank no-data
Country United States
IP Address 35.163.221.159

META INFORMATION

Title

CancerConnect

Description

Coalition of Mavens - Find your maven

Keywords

Content Type

utf-8

No	Meta Name	Value
1	viewport	width=device-width, initial-scale=1

GENERAL HTML INFORMATION

Type	Status
HTML 5
Responsive Website

HTML SIZE INFORMATION

Text / Code Ratio 0.79 %

news.cancerconnect.com has a website text/code ratio of 0.79 %. Search engine crawlers tend to not pick up pages with inadequate content.

IMPORTANT HTML TAGS AND COUNTS

Titles

No	Text
1	Top stories

No	Text
1	Ask the expert about pancreatic cancer

No	Text
1	Treatment of stage ıv kidney cancer
2	Tagrisso – first precision medicine approved for treatment of early stage nsclc
3	Von hippel lindau (vhl) disease
4	Tumor mutational burden ıdentifies cancer responsive to ımmunotherapy
5	Enzastaurin for glioblastoma
6	Hereditary colon cancer: questions & answers from the university of california
7	Overview of thyroid cancer
8	Reconstructing hope - survivors share their breast reconstruction stories
9	Community

No	Text
1	Pancreatic cancer

Text Styling

STRONG0
B0
EM0
I0
U0
CITE0

LINK ANALYSIS

Total Link Count: 65

Internal Link Count : 64

No	Text	Type
1	Top Stories	text
2	Newly Diagnosed	text
3	Treatment & Care	text
4	Survivors***p	text
5	-	empty
6	Pancreatic Cancer	text
7	Ask the Expert About Pancreatic Cancer	text
8	Read More	text
9	CAR T-Cell Therapy Treatment for Lymphoma - UpdateJul 24, 2020	image
10	-	empty
11	-	image
12	Treatment of Stage IV Kidney Cancer	text
13	Precision cancer medicines and immunotherapy are the mainstay of stage IV Kidney Cancer treatment.	text
14	Feb 15, 2020byHuaifa	image
15	1	text
16	-	image
17	Tagrisso – First Precision Medicine Approved for Treatment of Early Stage NSCLC	text
18	ASCO-FDA Updates - Pivotal ADAURA trial confirms Tagrisso delays cancer progression of EGFRm NSCLC.	text
19	Comment	text
20	-	image
21	Von Hippel Lindau (VHL) Disease	text
22	VHL is an inherited disease leading to cancer - recent development of MK-6482 may lead to improved outcomes.	text
23	Comment	text
24	-	image
25	Tumor Mutational Burden Identifies Cancer Responsive to Immunotherapy	text
26	FDA Approves Keytruda for Tumor Mutational Burden-High Cancer	text
27	Comment	text
28	-	image
29	Enzastaurin for Glioblastoma	text
30	Enzastaurin and other recent developments for treating Glioblastoma.	text
31	Comment	text
32	-	image
33	Hereditary Colon Cancer: Questions & Answers from The University of California	text
34	The main hereditary colon cancers are Lynch syndrome and hereditary nonpolyposis colorectal cancer: understand the risks	text
35	Comment	text
36	-	image
37	Overview of Thyroid Cancer	text
38	Understand the symptoms, signs, risk factors and diagnosis of thyroid cancers.	text
39	Comment	text
40	-	image
41	Reconstructing Hope - Survivors Share Their Breast Reconstruction Stories	text
42	Women share their stories, experience and tips for breast reconstruction.	text
43	Comment	text
44	Had BCG and GEM/DOC	text
45	Comment	text
46	A free online program: Learning how to manage emotions after cancer	text
47	Comment	text
48	I had IPMN and 30% of my pancreas resected Pathology of the cyst(post	text
49	1	text
50	How do families talk about Ovarian Cancer? - FREE UCSF Webinar	text